PMID- 33706717 OWN - NLM STAT- MEDLINE DCOM- 20210624 LR - 20210624 IS - 1471-2288 (Electronic) IS - 1471-2288 (Linking) VI - 21 IP - 1 DP - 2021 Mar 11 TI - Population segmentation of type 2 diabetes mellitus patients and its clinical applications - a scoping review. PG - 49 LID - 10.1186/s12874-021-01209-w [doi] LID - 49 AB - BACKGROUND: Population segmentation permits the division of a heterogeneous population into relatively homogenous subgroups. This scoping review aims to summarize the clinical applications of data driven and expert driven population segmentation among Type 2 diabetes mellitus (T2DM) patients. METHODS: The literature search was conducted in Medline(R), Embase(R), Scopus(R) and PsycInfo(R). Articles which utilized expert-based or data-driven population segmentation methodologies for evaluation of outcomes among T2DM patients were included. Population segmentation variables were grouped into five domains (socio-demographic, diabetes related, non-diabetes medical related, psychiatric / psychological and health system related variables). A framework for PopulAtion Segmentation Study design for T2DM patients (PASS-T2DM) was proposed. RESULTS: Of 155,124 articles screened, 148 articles were included. Expert driven population segmentation approach was most commonly used, of which judgemental splitting was the main strategy employed (n = 111, 75.0%). Cluster based analyses (n = 37, 25.0%) was the main data driven population segmentation strategies utilized. Socio-demographic (n = 66, 44.6%), diabetes related (n = 54, 36.5%) and non-diabetes medical related (n = 18, 12.2%) were the most used domains. Specifically, patients' race, age, Hba1c related parameters and depression / anxiety related variables were most frequently used. Health grouping/profiling (n = 71, 48%), assessment of diabetes related complications (n = 57, 38.5%) and non-diabetes metabolic derangements (n = 42, 28.4%) were the most frequent population segmentation objectives of the studies. CONCLUSIONS: Population segmentation has a wide range of clinical applications for evaluating clinical outcomes among T2DM patients. More studies are required to identify the optimal set of population segmentation framework for T2DM patients. FAU - Seng, Jun Jie Benjamin AU - Seng JJB AUID- ORCID: 0000-0002-3039-3816 AD - Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. AD - SingHealth Regional Health System PULSES Centre, Singapore Health Services, Outram Rd, Singapore, 169608, Singapore. FAU - Monteiro, Amelia Yuting AU - Monteiro AY AUID- ORCID: 0000-0001-8764-9627 AD - Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. FAU - Kwan, Yu Heng AU - Kwan YH AUID- ORCID: 0000-0001-7802-9696 AD - SingHealth Regional Health System PULSES Centre, Singapore Health Services, Outram Rd, Singapore, 169608, Singapore. AD - Program in Health Services and Systems Research, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. AD - Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore. FAU - Zainudin, Sueziani Binte AU - Zainudin SB AUID- ORCID: 0000-0003-1686-0358 AD - Department of General Medicine (Endocrinology), Sengkang General Hospital, Singapore, Singapore. FAU - Tan, Chuen Seng AU - Tan CS AUID- ORCID: 0000-0002-6513-2309 AD - Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Republic of Singapore. FAU - Thumboo, Julian AU - Thumboo J AUID- ORCID: 0000-0001-6712-5535 AD - SingHealth Regional Health System PULSES Centre, Singapore Health Services, Outram Rd, Singapore, 169608, Singapore. AD - Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore. AD - SingHealth Regional Health System, Singapore Health Services, Singapore, Singapore. FAU - Low, Lian Leng AU - Low LL AUID- ORCID: 0000-0003-4228-2862 AD - SingHealth Regional Health System PULSES Centre, Singapore Health Services, Outram Rd, Singapore, 169608, Singapore. low.lian.leng@singhealth.com.sg. AD - SingHealth Regional Health System, Singapore Health Services, Singapore, Singapore. low.lian.leng@singhealth.com.sg. AD - Department of Family Medicine and Continuing Care, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore. low.lian.leng@singhealth.com.sg. AD - SingHealth Duke-NUS Family Medicine Academic Clinical Program, Singapore, Singapore. low.lian.leng@singhealth.com.sg. AD - Outram Community Hospital, SingHealth Community Hospitals, 10 Hospital Boulevard, Singapore, 168582, Singapore. low.lian.leng@singhealth.com.sg. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20210311 PL - England TA - BMC Med Res Methodol JT - BMC medical research methodology JID - 100968545 SB - IM MH - *Diabetes Mellitus, Type 2/diagnosis/epidemiology MH - Humans PMC - PMC7953703 OTO - NOTNLM OT - Cluster analysis OT - Data analysis OT - Diabetes mellitus, type 2 OT - Latent class analysis OT - Outcome assessment, health care OT - Patient outcome assessment OT - Population segmentation OT - Scoping review COIS- The authors declare that they have no competing interests. EDAT- 2021/03/13 06:00 MHDA- 2021/06/25 06:00 PMCR- 2021/03/11 CRDT- 2021/03/12 05:46 PHST- 2020/07/08 00:00 [received] PHST- 2021/01/13 00:00 [accepted] PHST- 2021/03/12 05:46 [entrez] PHST- 2021/03/13 06:00 [pubmed] PHST- 2021/06/25 06:00 [medline] PHST- 2021/03/11 00:00 [pmc-release] AID - 10.1186/s12874-021-01209-w [pii] AID - 1209 [pii] AID - 10.1186/s12874-021-01209-w [doi] PST - epublish SO - BMC Med Res Methodol. 2021 Mar 11;21(1):49. doi: 10.1186/s12874-021-01209-w.